Linked Life Data

3146813

Source:http://linkedlifedata.com/resource/pubmed/id/3146813

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1989-3-22
pubmed:abstractText
RDS continues to be a major problem for premature infants despite a better understanding of its pathophysiology and of ways to try to prevent it. To date, prenatal administration of glucocorticoids has been the most widely used method of accelerating fetal lung development. However, several limitations of this therapy have prompted the search for alternative approaches. Most efforts have focused on the potential use of combined hormonal therapy with glucocorticoids and either thyroid hormones or TRH. The easy transplacental passage of the latter tends to favor its use. The use of hormonal therapy prenatally and surfactant administration at birth appears currently to be the best approach to prevent RDS. The greatest benefit would clearly come from the prevention of prematurity (Fig 1), but this has not proved to be an easy task.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0146-0005
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
348-58
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Prevention of respiratory distress syndrome.
pubmed:affiliation
Department of Pediatrics, Louisiana State University, New Orleans.
pubmed:publicationType
Journal Article, Review